(NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street.

Continuous glucose monitoring can now spot early diabetes risks, offering a non-invasive alternative to traditional blood ...

Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices ...

The integration between the Oura smart ring and Stelo is the culmination of a partnership between ŌURA and Dexcom in November ...

The cargo airline division of ocean shipping giant CMA CGM has more than doubled its small fleet with the acquisition of Air ...

Personal continuous glucose monitors are accurate at measuring glucose levels in most ranges for hospitalized patients with ...

The CMA CGM Group welcomed the arrival of the first Indian flagged containership registered by a major foreign carrier, CMA ...

Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of ...

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

Executives from CMA CGM and the Suez Canal Authority held talks this week to explore a full return to Suez Canal transits.

The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...

GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable ...